|
Warning Letter Prompts Hikma to Halt Production at NJ Generics Plant
Hikma Pharmaceuticals will cease commercial production at its Eatontown, N.J., plant through mid-January to focus on bringing the facility back into compliance with GMP regulations following a February 2012 warning letter.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives